Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells

Oncogene

Volumn 32, Issue 28, 2013, Pages 3339-3349

  Kim, K J ^a   Moon, S M ^a   Kim, S A ^b   Kang, K W ^c   Yoon, J H ^d   Ahn, S G ^a  

^a Chosun University   (South Korea)

^b Dongguk University   (South Korea)

^c Seoul National University   (South Korea)

^d Wonkwang University   (South Korea)

Author keywords

Apoptosis; HOXC6; MDR 1; Multidrug resistance (MDR)

Indexed keywords

HOMEOBOX C6 PROTEIN; HOMEODOMAIN PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INTRACELLULAR SPACE; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEIN; PROMOTER REGIONS, GENETIC; RHODAMINE 123; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84880288757     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.354     Document Type: Article

References (30)

1. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2002; 2: 777-785.
2. Veraksa A, Del Campo M, McGinnis W. Developmental patterning genes and their conserved functions: from model organisms to humans. Mol Genet Metab 2000; 69: 85-100.
3. Friedmann Y, Daniel CA, Strickland P, Daniel CW. Hox genes in normal and neoplastic mouse mammary gland. Cancer Res 1994; 54: 5981-5985.
4. Castronovo V, Kusaka M, Chariot A, Gielen J, Sobel M. Homeobox genes: potential candidates for the transcriptional control of the transformed and invasive phenotype. Biochem Pharmacol 1994; 47: 137-143.
5. Chen H, Sukumar S. HOX genes: emerging stars in cancer. Cancer Biol Ther 2003; 2: 524-525.
6. Bodey B, Bodey Jr B, Siegel SE, Kaiser HE. Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in breast carcinomas. Anticancer Res 2000; 20: 3281-3286.
7. Castronovo V, Kusaka M, Chariot A, Gielen J, Sobel M. Homeobox genes: potential candidates for the transcriptional control of the transformed and invasive phenotype. Biochem Pharmacol 1994; 47: 137-143.
8. Fujiki K, Duerr EM, Kikuchi H, Ng A, Xavier RJ, Mizukami Y et al. Hoxc6 is overexpressed in gastrointestinal carcinoids and interacts with JunD to regulate tumor growth. Gastroenterology 2008; 135: 907-916.
9. Bodey B, Bodey BJR, Siegel SE, Luck JV, Kaiser HE. Homeobox B3, B4, and C6 gene product expression in osteosarcomas as detected by immunocytochemistry. Anticancer Res 2000; 20: 2717-2721.
10. Miller GJ, Miller HL, van Bokhoven A, Lambert JR, Werahera PN, Schirripa O et al. Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Res 2003; 63: 5879-5888.
11. Garcia-Gasca A, Spyropoulos DD. Differential mammary morphogenesis along the anteroposterior axis in Hoxc6 gene targeted mice. Dev Dyn 2000; 219: 261-276.
12. Ramachandran S, Liu P, Young AN, Yin-Goen Q, Lim SD, Laycock N et al. Loss of HOXC6 expression induces apoptosis in prostate cancer cells. Oncogene 2005; 24: 188-198.
13. McCabe CD, Spyropoulos DD, Martin D, Moreno CS. Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer. Cancer Res 2008; 68: 1988-1996.
14. Grishina IB, Kim SY, Ferrara C, Makarenkova HP, Walden PD. BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling. Dev Biol 2005; 288: 334-347.
15. Ricort JM, Binoux M. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway. J Biol Chem 2002; 277: 19448-19454.
16. Van der Geer P, Hunter T, Lindberg RA. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 1994; 10: 251-337.
17. Lin Y, Liu G, Zhang Y, Hu YP, Yu K, Lin C et al. Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis. Development 2007; 134: 723-734.
18. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP dependent transporters. Nat Rev Cancer 2002; 2: 48-58.
19. Haimeur A, Conseil G, Deeley RG, Cole SP. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation. Curr Drug Metab 2004; 5: 21-53.
20. Szakacs G, Annereau JP, Lababidi S, Shankavaram U, Arciello A, Bussey KJ et al. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 2004; 6: 129-137.
21. Deeley RG, Cole SP. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett 2006; 580: 1103-1111.
22. Litman T, Druley TE, Stein WD, Bates SE. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 2001; 58: 931-959.
23. Cho S, Lu M, He X, Ee PL, Bhat U, Schneider E et al. Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells. Proc Natl Acad Sci USA 2011; 108: 20778-20783.
24. Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A et al. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am J Pathol 2002; 160: 2169-2180.
25. De Vita G, Barba P, Odartchenko N, Givel JC, Freschi G, Bucciarelli G et al. Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer 1993; 29: 887-893.
26. Tiberio C, Barba P, Magli MC, Arvelo F, Le Chevalier T, Poupon MF et al. HOX gene expression in human small-cell lung cancers xenografted into nude mice. Int J Cancer 1994; 58: 608-615.
27. Svingen T, Tonissen KF. Hox transcription factors and their elusive mammalian gene targets. Heredity 2006; 97: 88-96.
28. Jones FS, Holst BD, Minowa O, De Robertis EM, Edelman GM. Binding and transcriptional activation of the promoter for the neural cell adhesion molecule by HoxC6 (Hox-3.3). Proc Natl Acad Sci USA 1993; 90: 6557-6561.
29. Kim SA, Yoon JH, Ahn SG. Heat shock factor 4a (HSF4a) represses HSF2 expression and HSF2-mediated transcriptional activity. J Cell Physiol 2012; 227: 1-6.
30. Guo C, Ding J, Yao L, Sun L, Lin T, Song Y et al. Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int J Cancer 2005; 116: 155-160.